Silo Pharma, Inc. (SILO)
SILO Stock Price Chart
Explore Silo Pharma, Inc. interactive price chart. Choose custom timeframes to analyze SILO price movements and trends.
SILO Company Profile
Discover essential business fundamentals and corporate details for Silo Pharma, Inc. (SILO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
8 Jan 2021
Employees
3.00
Website
https://silopharma.comCEO
Eric Weisblum
Description
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.
SILO Financial Timeline
Browse a chronological timeline of Silo Pharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 7 May 2026
Upcoming earnings on 10 Nov 2025
Earnings released on 13 Aug 2025
EPS came in at -$0.19 , while revenue for the quarter reached $18.03K .
Earnings released on 9 May 2025
EPS came in at -$0.23 , while revenue for the quarter reached $18.03K .
Earnings released on 28 Mar 2025
EPS came in at -$0.41 , while revenue for the quarter reached $18.03K .
Earnings released on 12 Nov 2024
EPS came in at -$0.22 , while revenue for the quarter reached $18.03K .
Earnings released on 13 Aug 2024
EPS came in at -$0.31 , while revenue for the quarter reached $18.03K .
Earnings released on 13 May 2024
EPS came in at -$0.28 , while revenue for the quarter reached $18.03K .
Earnings released on 25 Mar 2024
EPS came in at -$0.36 falling short of the estimated -$0.20 by -80.00%, while revenue for the quarter reached $18.03K , beating expectations by +0.14%.
Earnings released on 13 Nov 2023
EPS came in at -$0.21 matching the estimated -$0.21, while revenue for the quarter reached $18.03K , beating expectations by +0.14%.
Earnings released on 12 Aug 2023
EPS came in at -$0.32 falling short of the estimated -$0.32 by -0.37%, while revenue for the quarter reached $18.03K , beating expectations by +0.14%.
Earnings released on 12 May 2023
EPS came in at -$0.29 , while revenue for the quarter reached $18.03K .
Earnings released on 24 Mar 2023
EPS came in at -$0.78 , while revenue for the quarter reached $18.03K .
Earnings released on 10 Nov 2022
EPS came in at -$0.51 , while revenue for the quarter reached $18.03K .
Stock split effective on 19 Sept 2022
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 15 Sept 2022
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 1 Aug 2022
EPS came in at -$0.41 , while revenue for the quarter reached $18.03K .
Earnings released on 13 May 2022
EPS came in at -$0.31 , while revenue for the quarter reached $18.03K .
Earnings released on 28 Mar 2022
EPS came in at -$0.57 , while revenue for the quarter reached $18.03K .
Earnings released on 11 Nov 2021
EPS came in at $3.20 , while revenue for the quarter reached $18.03K .
Earnings released on 13 Aug 2021
EPS came in at -$0.24 , while revenue for the quarter reached $68.09K .
Earnings released on 17 May 2021
EPS came in at -$0.55 , while revenue for the quarter reached $47.43K .
Earnings released on 29 Mar 2021
EPS came in at -$0.60 , while revenue for the quarter reached $22.13K .
Earnings released on 5 Nov 2020
EPS came in at -$0.38 , while revenue for the quarter reached $16.29K .
SILO Stock Performance
Access detailed SILO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.